EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Contrast Media/Contrast Agent Market by Type (Iodinated, Gadolinium, Barium, & Microbubble), Procedure (X-Ray/CT, MRI, & Ultrasound) & Application (Radiology, Interventional Radiology, & Interventional Cardiology) - Global Forecasts to 2021

  • ID: 3939169
  • Report
  • October 2016
  • Region: Global
  • 162 Pages
  • Markets and Markets
1 of 4
Global Contrast Agents/Contrast Media Market is Projected to Reach USD 5.44 Billion by 2021 from USD 4.46 Billion in 2016 Growing at a CAGR of 4.1%

FEATURED COMPANIES

  • Bayer AG
  • Bracco Imaging S.P.A.
  • CMC Contrast AB
  • Daiichi Sankyo
  • GE Healthcare
  • Guerbet Group
  • MORE

The global contrast media/contrast agents market is projected to reach USD 5.44 billion by 2021 from USD 4.46 billion in 2016 growing at a CAGR of 4.1% during the forecast period.

The contrast media/contrast agents market has witnessed various advancements in products and their approvals to meet the needs of patients and radiologists worldwide. These advancements have led to the improved use of many existing contrast agents as well as the introduction of new ones.

Factors such as increasing approvals for contrast agents and increase in the number of public and private diagnostic centers to improve diagnostic imaging services are driving the demand of various diagnostic imaging modalities. Moreover, strong product pipelines of the market players, coupled with the increasing research studies regarding applications of various contrast agents, are expected to create opportunities for market growth in the near future. However side effects, adverse and allergic reactions associated with contrast agents are restraining the growth of the market to a certain extent.

In 2016, the iodinated contrast media segment expected to account for the largest share of the global contrast media/contrast agents market, among type of contrast media; the injectable contrast media segment is expected to account for the largest share of the global contrast media/contrast agents market, among the routes of administration; the X-ray/CT segment is expected to dominate the global contrast media/contrast agents market, among procedures; the cardiovascular disorders segment is expected to account for the largest share of the global contrast media/contrast agents market, among indications; and the radiology segment is expected to dominate the contrast media/contrast agents market, among applications.

In 2016, North America is estimated to be the largest market for contrast media/contrast agents, globally, followed by Europe, Asia-Pacific, and Rest of the World (RoW). In the coming years, the contrast media/contrast agents market is expected to witness the highest growth rate in the European region. The high growth in this region can be attributed to the increasing research & development investments by market players, increasing incidences and prevalence of cancer, and increasing number of MRI and CT scanners.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies such as product approvals, agreements, collaborations, contract, and partnerships; expansions; and other strategies (divestment, grant, insurance coverage approval and acquisition) to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the contrast media/contrast agents market.

- By Company Type: Tier 1: 52%, Tier 2: 39%, Tier 3: 9%
- By Designation: Director Level: 19%, C-Level: 28%, Others: 53%
- By Region: North America: 27%, Europe: 27%, APAC: 30%, RoW: 16%

The prominent players in the global contrast media/ contrast agents market include Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy) in 2015. These companies are dominant in the contrast media/contrast agents market mainly due to their well-established presence in the field of contrast media, presence in over 50 countries, high R&D investments, and strong sales and distribution force. Other players operating in this market include Lantheus Medical Imaging (U.S.), nanoPET GmbH (Germany), CMC Contrast AB (Sweden), Daiichi Sankyo (Japan), and Subhra Pharma Private Limited (India).

Research Coverage

The report provides a picture of the contrast media/contrast agents market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by type, procedure, route of administration, indication, application, and regions. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, product pipeline and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater share of the concerned market. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the contrast media/contrast agents market - the report analyzes the contrast media/contrast agents market, on the basis of type, route of administration, procedure, indication, and application
- Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, product approvals, and new product launches in the contrast media/contrast agents market
- Market Development: Comprehensive information about the lucrative emerging markets - the report analyzes the markets for various contrast media/contrast agents across regions
- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the contrast media/contrast agents market
- Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the contrast media/contrast agents market

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Bracco Imaging S.P.A.
  • CMC Contrast AB
  • Daiichi Sankyo
  • GE Healthcare
  • Guerbet Group
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Insights From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Forecast Methodology
2.5 Market Data Validation and Triangulation
2.6 Assumptions

3 Executive Summary
3.1 Introduction
3.2 Conclusion

4 Premium Insights
4.1 Contrast Media Market Overview
4.2 Contrast Media Market, By Type and Route of Administration (2016)
4.3 Geographic Snapshot: Contrast Media Market
4.4 Global Contrast Media Market, By Indication (2016 vs 2021)

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Large Number of Approvals for Contrast Agents
5.2.1.2 Increasing Number of Public and Private Diagnostic Centers
5.2.2 Restraint
5.2.2.1 Side Effects and Allergic Reactions Associated With Contrast Agents
5.2.3 Opportunity
5.2.3.1 Increasing Number of Research and Funding Activities for Contrast Agents
5.2.4 Challenges
5.2.4.1 Development of Gamma and Neutron Imaging Solutions
5.2.4.2 Need for Highly Skilled Professionals

6 Pipeline Assessment
6.1 Introduction
6.1.1 Clinical Trials Using Contrast Media
6.1.2 Product Pipeline

7 Global Contrast Media Market, By Type
7.1 Introduction
7.2 Iodinated Contrasts Media
7.3 Gadolinium-Based Contrasts Media
7.4 Microbubble Contrasts Media
7.5 Barium- Based Contrasts Media

8 Global Contrast Media Market, By Medical Procedure
8.1 Introduction
8.2 X-Ray/CT
8.3 MRI
8.4 Ultrasound

9 Global Contrast Media Market, By Route of Administration
9.1 Introduction
9.2 Injectable Contrasts Media
9.3 Oral Contrasts Media
9.4 Rectal Contrasts Media
9.5 Urethral Contrasts Media

10 Global Contrast Media Market, By Indication
10.1 Introduction
10.2 Cardiovascular Disorders
10.3 Oncology
10.4 Gastrointestinal Disorders
10.5 Neurological Disorders
10.6 Nephrological Disorders
10.7 Musculoskeletal Disorders

11 Global Contrast Media Market, By Application
11.1 Introduction
11.2 Radiology
11.3 Interventional Cardiology
11.4 Interventional Radiology

12 Contrast Media Market, By Region
12.1 Introduction
12.2 North America
12.2.1 U.S.
12.2.1.1 Increasing Number of Diagnostic Imaging Tests and Centers
12.2.1.2 Rising Aging Population, Rising Prevalence of Chronic Diseases
12.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias
12.2.2 Canada
12.2.2.1 Rising Aging Population, High Incidence of Cancer, Cvd, and Diabetes
12.2.2.2 Increasing MRI and CT Examinations
12.2.2.3 Increasing Research Activities
12.3 Europe
12.3.1 Europe 5
12.3.1.1 Increase in Investments By Market Players
12.3.1.2 Increasing Incidence and Prevalence of Cancer
12.3.1.3 U.K.: Lack of Sufficient Instruments
12.3.1.4 Conferences/Meetings/Symposiums/Workshops in Europe
12.3.2 RoE
12.3.2.1 Increase Focus of Market Players on RoE Countries
12.4 Asia-Pacific
12.4.1 Rise in Aging Population and Cancer Incidence
12.4.2 Expansion of International Players in China and India
12.4.3 Increasing R&D Investments in China
12.4.4 Favorable Regulatory Changes in New Zealand and Australia
12.4.5 Increasing Research Activities in Asia-Pacific
12.5 Rest of the World
12.5.1 Latin America
12.5.2 The Middle East
12.5.3 Africa

13 Competitive Landscape
13.1 Overview
13.2 Market Share Analysis
13.2.1 Bayer Healthcare
13.2.2 GE Healthcare
13.3 Competitive Scenario
13.3.1 Market Developments (Product Approvals)
13.3.2 Agreements, Collaborations, Contracts, and Partnerships
13.3.3 Expansions
13.3.4 Other Strategies

14 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, View) -
14.1 Introduction
14.2 GE Healthcare
14.3 Bayer AG
14.4 Bracco Imaging S.P.A.
14.5 Guerbet Group
14.6 Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
14.7 Nanopet Pharma GmbH
14.8 CMC Contrast AB
14.9 Daiichi Sankyo
14.10 Subhra Pharma Private Limited
14.11 Spago Nanomedical AB

- Details on View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables

Table 1 Indicative List of Research Studies Undertaken By Research Institutes and Universities
Table 2 Indicative List of Clinical Trials Conducted for Contrast Media
Table 3 Indicative List of Product Pipeline for Contrast Media
Table 4 Market Size, By Type, 2014-2021 (USD Million)
Table 5 Iodinated Market Size, By Region, 2014-2021 (USD Million)
Table 6 Gadolinium-Based Market Size, By Region, 2014-2021 (USD Million)
Table 7 Microbubble Market Size, By Region, 2014-2021 (USD Million)
Table 8 Barium-Based Market Size, By Region, 2014-2021 (USD Million)
Table 9 Market Size, By Medical Procedure, 2014-2021 (USD Million)
Table 10 Market Size for X-Ray/CT Procedures, By Region, 2014-2021 (USD Million)
Table 11 Market Size for MRI Procedures, By Region, 2014-2021 (USD Million)
Table 12 Market Size for Ultrasound Procedures, By Region, 2014-2021 (USD Million)
Table 13 Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 14 Injectable Market Size, By Region, 2014-2021 (USD Million)
Table 15 Oral Market Size, By Region, 2014-2021 (USD Million)
Table 16 Rectal Contrast Media Market Size, By Region, 2014-2021 (USD Million)
Table 17 Urethral Contrast Media Market Size, By Region, 2014-2021 (USD Million)
Table 18 Market Size, By Indication, 2014-2021 (USD Million)
Table 19 Market Size for Cardiovascular Disorders, By Region, 2014-2021 (USD Million)
Table 20 Market Size for Oncology, By Region, 2014-2021 (USD Million)
Table 21 Market Size for Gastrointestinal Disorders, By Region, 2014-2021 (USD Million)
Table 22 Market Size for Neurological Disorders, By Region, 2014-2021 (USD Million)
Table 23 Market Size for Nephrological Disorders, By Region, 2014-2021 (USD Million)
Table 24 Market Size for Musculoskeletal Disorders, By Region, 2014-2021 (USD Million)
Table 25 Market Size, By Application, 2014-2021 (USD Million)
Table 26 Market Size for Radiology, By Region, 2014-2021 (USD Million)
Table 27 Market Size for Interventional Cardiology, By Region, 2014-2021 (USD Million)
Table 28 Market Size for Interventional Radiology, By Region, 2014-2021 (USD Million)
Table 29 Market Size, By Region, 2014-2021 (USD Million)
Table 30 North America: Market Size, By Procedure, 2014-2021 (USD Million)
Table 31 North America: Market Size, By Type, 2014-2021 (USD Million)
Table 32 North America: Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 33 North America: Market Size, By Indication, 2014-2021 (USD Million)
Table 34 North America: Market Size, By Application, 2014-2021 (USD Million)
Table 35 U.S.: Market Size, By Procedure, 2014-2021 (USD Million)
Table 36 U.S.: Market Size, By Type, 2014-2021 (USD Million)
Table 37 U.S.: Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 38 U.S.: Market Size, By Indication, 2014-2021 (USD Million)
Table 39 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 40 Research Projects in Canada, 2013-2016
Table 41 Canada: Market Size, By Procedure, 2014-2021 (USD Million)
Table 42 Canada: Market Size, By Type, 2014-2021 (USD Million)
Table 43 Canada: Contrast Media Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 44 Canada: Contrast Media Market Size, By Indication, 2014-2021 (USD Million)
Table 45 Canada: Contrast Media Market Size, By Application, 2014-2021 (USD Million)
Table 46 Europe: Contrast Media Market Size, By Country, 2014-2021 (USD Million)
Table 47 Europe: Contrast Media Market Size, By Procedure, 2014-2021 (USD Million)
Table 48 Europe: Contrast Agents Market Size, By Type, 2014-2021 (USD Million)
Table 49 Europe: Contrast Agents Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 50 Europe: Contrast Agents Market Size, By Indication, 2014-2021 (USD Million)
Table 51 Europe: Contrast Agents Market Size, By Application, 2014-2021 (USD Million)
Table 52 Indicative List of Upcoming Events in Europe
Table 53 Europe 5: Contrast Agents Market Size, By Procedure, 2014-2021 (USD Million)
Table 54 Europe 5: Contrast Agents Market Size, By Type, 2014-2021 (USD Million)
Table 55 Europe 5: Contrast Agents Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 56 Europe 5: Contrast Agents Market Size, By Indication, 2014-2021 (USD Million)
Table 57 Europe 5: Contrast Agents Market Size, By Application, 2014-2021 (USD Million)
Table 58 RoE: Contrast Agents Market Size, By Procedure, 2014-2021 (USD Million)
Table 59 RoE: Contrast Agents Market Size, By Type, 2014-2021 (USD Million)
Table 60 RoE: Contrast Agents Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 61 RoE: Contrast Agents Market Size, By Indication 2014-2021 (USD Million)
Table 62 RoE: Contrast Agents Market Size, By Application, 2014-2021 (USD Million)
Table 63 Research Projects in Asia-Pacific, 2013-2016
Table 64 APAC: Contrast Agents Market Size, By Procedure, 2014-2021 (USD Million)
Table 65 APAC: Contrast Agents Market Size, By Type, 2014-2021 (USD Million)
Table 66 APAC: Contrast Agents Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 67 APAC: Contrast Agents Market Size, By Indication 2014-2021 (USD Million)
Table 68 APAC: Contrast Agents Market Size, By Application, 2014-2021 (USD Million)
Table 69 RoW: Contrast Agents Market Size, By Procedure, 2014-2021 (USD Million)
Table 70 RoW: Contrast Agents Market Size, By Type, 2014-2021 (USD Million)
Table 71 RoW: Contrast Agents Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 72 RoW: Contrast Agents Market Size, By Indication 2014-2021 (USD Million)
Table 73 RoW: Contrast Media Market Size, By Application, 2014-2021 (USD Million)
Table 74 Market Developments (Product Approvals), 2013-2016
Table 75 Agreements, Collaborations, Contracts, and Partnerships, 2013-2016
Table 76 Expansions, 2013-2016
Table 77 Other Strategies, 2013-2016

List of Figures

Figure 1 Research Methodology: Global Contrast Media/Contrast Agents Market
Figure 2 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Sampling Frame: Primary Research
Figure 4 Key Data From Primary Sources
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Research Design: Global Contrast Media/ Contrast Agents Market
Figure 8 Data Triangulation Methodology
Figure 9 Contrast Media/Contrast Agents Market, By Procedure (2016)
Figure 10 Contrast Media/Contrast Agents Market, By Route of Administration, 2016 vs 2021
Figure 11 Contrast Media/Contrast Agents Market, By Indication, 2016 vs 2021
Figure 12 Contrast Media/Contrast Agents Market Analysis, By Application, 2016 vs 2021
Figure 13 Europe is Slated to Witness the Highest Growth in the Contrast Media/Contrast Agents Market During the Forecast Period
Figure 14 North America to Account for the Largest Market Share in 2016
Figure 15 Iodinated Contrast Media Segment to Dominate the Market in 2016
Figure 16 Europe to Witness Highest Growth During the Forecast Period
Figure 17 Cardiovascular Disorders to Command the Largest Market Share in 2016
Figure 18 Drivers, Restraints, Opportunities, & Challenges
Figure 19 Clinical Trials for Contrast Media/Contrast Agents, By Phase
Figure 20 Clinical Trials for Contrast Media/Contrast Agents, By Indication (2013-2016)
Figure 21 Microbubble Contrast Media to Form the Fastest-Growing Segment During the Forecast Period
Figure 22 X-Ray/CT Accounts for the Largest Share of the Contrast Media Market
Figure 23 Injectable Contrast Media/Contrast Agents are the Largest and Fastest-Growing Segment in the Contrast Media/Contrast Agents Market, By Route of Administration
Figure 24 Cardiovascular Disorders to Dominate the Contrast Media Market
Figure 25 Radiology to Account for the Largest Share of the Contrast Media Market, By Application (2016)
Figure 26 North America Commanded the Largest Share of the Contrast Media Market
Figure 27 North America: Contrast Media Market Snapshot
Figure 28 Prevalence of Alzheimer's Disease in the U.S., By Age Group, 2015
Figure 29 Europe: Contrast Media Market Snapshot
Figure 30 Asia-Pacific: Contrast Media Market Snapshot
Figure 31 RoW: Contrast Media Market Snapshot
Figure 32 Global Contrast Media Market Share, By Key Player, 2015
Figure 33 Key Developments of the Prominent Players in the Contrast Media Market (2013-2016)
Figure 34 Market Developments (Product Approvals) Key Growth Strategy Adopted By Market Players From 2013 to 2016
Figure 35 Product Mix of the Prominent Players in the Contrast Media Market
Figure 36 GE Healthcare: Company Snapshot
Figure 37 Bayer Healthcare: Company Snapshot
Figure 38 Guerbet Group: Company Snapshot
Figure 39 Lantheus Medical Imaging: Company Snapshot
Figure 40 Daiichi Sankyo: Company Snapshot
Figure 41 Spago Nanomedical AB: Company Snapshot

Note: Product cover images may vary from those shown
3 of 4

FEATURED COMPANIES

  • Bayer AG
  • Bracco Imaging S.P.A.
  • CMC Contrast AB
  • Daiichi Sankyo
  • GE Healthcare
  • Guerbet Group
  • MORE

The global contrast agents/contrast media market is projected to reach USD 5.44 Billion by 2021 from USD 4.46 Billion in 2016 growing at a CAGR of 4.1% during the forecast period. This growth can be attributed to factors such as increasing approvals for contrast agents and increase in the number of public and private diagnostic centers to improve diagnostic imaging services are driving the demand of various diagnostic imaging modalities. Moreover, strong product pipelines of the market players, coupled with the increasing research studies regarding applications of various contrast agents, are expected to drive the market in the near future.

The market has been segmented on the basis of type, procedure, indication, route of administration, application, and region. Based on route of administration, the overall market has been segmented into oral, injectable, rectal, and urethral routes. The injectable segment is expected to account for the largest share of the market, among the different routes of administration. The large share of this segment can be attributed to advancements in CT and MRI imaging technologies, which majorly use injectable contrast media.

Based on indication, the market is segmented into cardiovascular disorders, oncology, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is estimated to account for the largest share of the global market, by indication in 2016. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and strong healthcare infrastructure in countries like the U.S., Canada, the U.K., and Germany are some of the factors driving the growth of this segment.

Based on procedure, the global contrast media market is segmented into X-ray/CT, MRI, and ultrasound. The X-ray/CT segment is expected to account for the largest share of the market, among the procedures in 2016. However, the ultrasound segment is expected to register the highest CAGR during the forecast period. Development of microbubble contrast media for ultrasound, large number of approvals for ultrasound contrast media in the U.S., Europe, and Japan are some of the major factors driving the growth of this segment.

Based on application, the global market is segmented into radiology, interventional radiology, and interventional cardiology. The radiology segment is expected to account for the largest share of the market, among the applications in 2016. The large share of this segment can be attributed to the growing number of diagnostic procedures/centers coupled with the increasing disease burden on countries.

Based on region, the global market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is estimated to account for the largest share, followed by Europe and Asia-Pacific. However, the European market is expected to grow at the highest CAGR during the forecast period, and will also serve as a revenue pocket for companies offering contrast media/contrast agents in the near future. The high growth in this region can be attributed to the increasing research & development investments by market players, increasing incidence and prevalence of cancer, and increasing number of MRI and CT scanners.

Contrast Media Market

The prominent players in the global market include Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), and Bracco Imaging S.p.A. (Italy). These companies are dominant in the contrast agents/contrast media market mainly due to their well-established presence in the field of genomics, presence in over 50 countries, high R&D investments, and strong sales and distribution force. Other players operating in this market include Lantheus Medical Imaging (U.S.), nanoPET Pharma GmbH (Germany), CMC Contrast AB (Sweden) Daiichi Sankyo (Japan), and Subhra Pharma Private Limited (India).

Note: Product cover images may vary from those shown
4 of 4

- Bayer AG
- Bracco Imaging S.P.A.
- CMC Contrast AB
- Daiichi Sankyo
- GE Healthcare
- Guerbet Group
- Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
- Nanopet Pharma GmbH
- Spago Nanomedical AB
- Subhra Pharma Private Limited

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll